AllianceBernstein’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-229,567
| Closed | -$37.9M | – | 3422 |
|
|
2021
Q2 | $37.9M | Buy |
229,567
+21,163
| +10% | +$3.53M | 0.02% | 695 |
|
|
2021
Q1 | $32M | Buy |
208,404
+106,225
| +104% | +$14.4M | 0.01% | 759 |
|
|
2020
Q4 | $12.8M | Sell |
102,179
-1,736
| -2% | -$194K | 0.01% | 1019 |
|
|
2020
Q3 | $10.5M | Sell |
103,915
-10,240
| -9% | -$1.04M | 0.01% | 1016 |
|
|
2020
Q2 | $11.1M | Sell |
114,155
-4,090
| -3% | -$381K | 0.01% | 962 |
|
|
2020
Q1 | $9.82M | Sell |
118,245
-580
| -0.5% | -$56.6K | 0.01% | 920 |
|
|
2019
Q4 | $13.2M | Buy |
118,825
+950
| +0.8% | +$97.7K | 0.01% | 969 |
|
|
2019
Q3 | $11.7M | Sell |
117,875
-29,296
| -20% | -$2.91M | 0.01% | 985 |
|
|
2019
Q2 | $14.6M | Sell |
147,171
-22,507
| -13% | -$2.15M | 0.01% | 908 |
|
|
2019
Q1 | $18.7M | Buy |
169,678
+55,499
| +49% | +$5.8M | 0.01% | 823 |
|
|
2018
Q4 | $10.5M | Buy |
114,179
+63,860
| +127% | +$6.46M | 0.01% | 969 |
|
|
2018
Q3 | $5.54M | Sell |
50,319
-6,729
| -12% | -$701K | ﹤0.01% | 1227 |
|
|
2018
Q2 | $5.33M | Sell |
57,048
-42,788
| -43% | -$3.68M | ﹤0.01% | 1204 |
|
|
2018
Q1 | $8.28M | Sell |
99,836
-1,100
| -1% | -$97.7K | 0.01% | 1002 |
|
|
2017
Q4 | $9.19M | Sell |
100,936
-4,940
| -5% | -$411K | 0.01% | 971 |
|
|
2017
Q3 | $8.06M | Buy |
105,876
+28,709
| +37% | +$2.17M | 0.01% | 1011 |
|
|
2017
Q2 | $5.79M | Buy |
77,167
+15,900
| +26% | +$1.1M | ﹤0.01% | 1141 |
|
|
2017
Q1 | $4M | Buy |
61,267
+20,403
| +50% | +$1.2M | ﹤0.01% | 1328 |
|
|
2016
Q4 | $2.25M | Sell |
40,864
-3,500
| -8% | -$192K | ﹤0.01% | 1739 |
|
|
2016
Q3 | $2.51M | Buy |
44,364
+17
| +0% | +$834 | ﹤0.01% | 1604 |
|
|
2016
Q2 | $1.85M | Buy |
44,347
+14,000
| +46% | +$645K | ﹤0.01% | 1784 |
|
|
2016
Q1 | $1.3M | Buy |
30,347
+400
| +1% | +$16.9K | ﹤0.01% | 1931 |
|
|
2015
Q4 | $1.36M | Sell |
29,947
-730
| -2% | -$30.7K | ﹤0.01% | 1929 |
|
|
2015
Q3 | $1.19M | Sell |
30,677
-70
| -0.2% | -$2.8K | ﹤0.01% | 2048 |
|
|
2015
Q2 | $1.12M | Buy |
30,747
+14,400
| +88% | +$455K | ﹤0.01% | 2209 |
|
|
2015
Q1 | $471K | Buy |
16,347
+14,400
| +740% | +$402K | ﹤0.01% | 2513 |
|
|
2014
Q4 | $47K | Buy |
+1,947
| New | +$43.9K | ﹤0.01% | 3112 |
|
Other funds holding PRAH
AllianceBernstein's PRAH Position: Q3 2021 in Review
AllianceBernstein sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 229,567 shares — an estimated $37.9M sold.
AllianceBernstein first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $37.9M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- AllianceBernstein reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- AllianceBernstein sold 229,567 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $37.9M.
- AllianceBernstein first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- AllianceBernstein's PRA Health Sciences, Inc. position peaked at $37.9M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.